<code id='3AF6CA3E90'></code><style id='3AF6CA3E90'></style>
    • <acronym id='3AF6CA3E90'></acronym>
      <center id='3AF6CA3E90'><center id='3AF6CA3E90'><tfoot id='3AF6CA3E90'></tfoot></center><abbr id='3AF6CA3E90'><dir id='3AF6CA3E90'><tfoot id='3AF6CA3E90'></tfoot><noframes id='3AF6CA3E90'>

    • <optgroup id='3AF6CA3E90'><strike id='3AF6CA3E90'><sup id='3AF6CA3E90'></sup></strike><code id='3AF6CA3E90'></code></optgroup>
        1. <b id='3AF6CA3E90'><label id='3AF6CA3E90'><select id='3AF6CA3E90'><dt id='3AF6CA3E90'><span id='3AF6CA3E90'></span></dt></select></label></b><u id='3AF6CA3E90'></u>
          <i id='3AF6CA3E90'><strike id='3AF6CA3E90'><tt id='3AF6CA3E90'><pre id='3AF6CA3E90'></pre></tt></strike></i>

          explore

          explore

          author:leisure time    Page View:46
          Change Healthcare logo, displayed on a screen, as seen through a magnifying glass — coverage from STAT
          Adobe

          Medicare announced on Saturday that it will make advance payments available to physician groups, hospitals, and other health care facilities as part of its response to the February 21 Change Healthcare cyberattack.

          The payments are meant to fund providers that aren’t able to submit claims to Medicare because of the disruption to Change’s data network and have exhausted all other potential avenues of funding. Medicare will advance up to 30 days of payment, based on the average monthly amount a provider received from Medicare from August 1 to October 31, 2023. The providers are expected to repay the money 90 days after receiving the payment, with interest beginning to accrue 30 days after that.

          advertisement

          “We welcome today’s announcement and will continue to work with policymakers as the impacts from the cyberattack persist,” the American Hospital Association said in a statement after the announcement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          Listen: More tumult at BIO & coercive care for sickle cell patients
          Listen: More tumult at BIO & coercive care for sickle cell patients

          Howdoesadrugindustrylobbyinggroupmoveforwardafteryearsofupheaval,includinghavingfourCEOsinfouryears?

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

          DarronCummings/APWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechne